GSMS Incorporated — Class II drug recall D-0587-2026
Ongoing recall by Golden State Medical Supply Inc., reported 2026-06-17. Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specifi
| Recall number | D-0587-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2026-05-29 |
| Classified | 2026-06-11 |
| Reported by FDA | 2026-06-17 |
| Quantity | 2,961 bottles |
| Reason classes | specification failure |
| NDC | 51407-0267, 51407-0267-90, 51407-0268, 51407-0268-90 |
| Lot numbers | GS065128, GS065844, GS066695, GS067432, GS067993 |
| Expiration dates | 2027-01-31 |
Product
GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.
Reason for recall
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0587-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.